首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Pharmacology And Experimental Therapeutics

Journal Of Pharmacology And Experimental Therapeutics杂志,由American Society for Pharmacology and Experimental Therapeutics出版,于1909年创刊,Monthly,出版语言English,ISSN:0022-3565,E-ISSN:1521-0103。

投稿咨询
Journal Of Pharmacology And Experimental Therapeutics
Journal Of Pharmacology And Experimental Therapeutics
Journal Of Pharmacology And Experimental Therapeutics
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
4.3
CiteScore
5.2
期刊收录
SCI、SCIE

Journal Of Pharmacology And Experimental Therapeutics(中文译名:《药理学与实验治疗学杂志》),ISSN:0022-3565,EISSN:1521-0103,是American Society for Pharmacology and Experimental Therapeutics出版的国际性学术期刊,创刊于1909年,以Monthly形式稳定发行,2026年总发文量约285篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.3,2025年期刊CiteScore为5.2,2025年期刊自引率约9.3%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Pharmacology And Experimental Therapeutics长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约1.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Japan、England、Canada、GERMANY (FED REP GER)、Italy等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMUNIVERSITY OF TEXAS SYSTEM、STATE UNIVERSITY OF NEW YORK (SUNY) SYSTEM、VIRGINIA COMMONWEALTH UNIVERSITY、US DEPARTMENT OF VETERANS AFFAIRS、PENNSYLVANIA COMMONWEALTH SYSTEM OF HIGHER EDUCATION (PCSHE)、STATE UNIVERSITY SYSTEM OF FLORIDA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 95 / 356

73.5

学科:PHARMACOLOGY & PHARMACY SCIE Q1 68 / 356

81.04

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 92 / 352

74

学科:PHARMACOLOGY & PHARMACY SCIE Q1 68 / 353

80.88


中国学者近期发文

1
SOX11-mediated CXCL10/CXCR3 activation promotes neuroendocrine prostate cance

Author:Ding, Hekang; Meng, Qingwei; He, Kun; Chen, Ziqi; Tang, Yi; Yang, Yige; Wang, Xu; Zhao, Bing; Xu, Lingfan

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 5, pp. -. DOI: 10.1016/j.jpet.2026.104320

2
Ameliorative effects of NAD plus on D-galactose-induced senescence and susceptibility to Acinetobacter baumannii pneumonia via antioxidant and immune modulatio

Author:Wang, Liping; Dong, Liying; Xia, Xue; Tang, Huaqiao; Cheng, Guoqiang; He, Tiantian; Tang, Daxuan; Zhang, Li

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 4, pp. -. DOI: 10.1016/j.jpet.2026.104314

3
Drug-drug interactions of antidepressant ammoxetine mediated by cytochrome P450 2D6 and multidrug and toxin extrusion protein 1: From in vitro mechanistic investigations to in vivo validatio

Author:Hu, Juanwen; Liu, Zhihui; Zhang, Qiannan; Li, Cong; Wu, Xia; Zhang, Wenpeng; Zhang, Youzhi; Zhuang, Xiaomei

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 4, pp. -. DOI: 10.1016/j.jpet.2026.104312

4
Targeting cholangiocyte sphingosine-1-phosphate (S1P) receptor 1 signaling alleviates cholestatic liver injury: Mechanistic insight into S1P/phosphorylated signal transducer and activator of transcription 3 axi

Author:Yuan, Zihang; Wang, Jie; Zhang, Haoran; Miao, Yingying; Chai, Yuanyuan; Li, Anqin; Tang, Qianhui; Chen, Qingyu; Zhang, Luyong; Yu, Qinwei; Jiang, Zhenzhou

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 4, pp. -. DOI: 10.1016/j.jpet.2026.104306

5
Multiomics and experimental validation reveal theophylline's mechanism targeting IL1A/ACTB/TLR4 and identify synergistic drugs in hepatocellular carcinom

Author:Gao, Yuxiang; Chen, Wei; Zarogoulidis, Paul; Yallapu, Murali M.; V. Nikolic, Milos; Vaishnani, Deep K.; Zheng, Jianjian; Nedeljkovic, Nikola; Ye, Kexin; Guo, Yong; Xu, Qiyu

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 3, pp. -. DOI: 10.1016/j.jpet.2026.103836

6
Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease (vol. 350, pg. 361, 2014

Author:Peng, Ying; Hu, Yanli; Xu, Shaofeng; Rong, Xianfang; Li, Jiang; Li, Pingping; Wang, Ling; Yang, Jinghua; Wang, Xiaoliang

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 1, pp. -. DOI: 10.1016/j.jpet.2025.103763

7
Salusin a counteracts salusin 3 to attenuate artery medial calcification through the inhibition of oxidative stress and extracellular signal-regulated protein kinases signaling pathway in rats with chronic kidney diseas

Author:Gao, Qing; Wang, Mei; Cao, Wen-Juan; Xia, Chen-Xi; Zhu, Han-Xu; Tang, Rong-Jie; Zhou, Ye-Bo; Chen, Lei-Lei

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2026; Vol. 393, Issue 1, pp. -. DOI: 10.1016/j.jpet.2025.103793

8
Alleviation of metabolic dysfunction-associated steatotic liver disease by silymarin is associated with maintaining mitochondrial homeostasis via regulation of optic atrophy

Author:Liu, Ming-qiang; Wu, Yuan; Li, Ye; Wei, Yan-bo; Dong, Ling-yue; An, Wei

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 7, pp. -. DOI: 10.1016/j.jpet.2025.103611

9
Hesperidin improves cardiac fibrosis induced by b-adrenergic activation through modulation of gut microbiot

Author:Liu, Xia; Ju, Weiwei; Qiang, Erjiao; Li, Dongning; Liang, Qing; Guo, Meina; Yun, Weijing; Chen, Zhenzhen

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 6, pp. -. DOI: 10.1016/j.jpet.2025.103578

10
Enhanced negative modulation of urotensin II on cardiac function and [Ca2+]i regulation in a diabetic rat model: Insights into molecular and cellular mechanism

Author:Zhang, Xiaowei; Chen, Zhe; Cao, Jing; Zhou, Peng; Zhang, Zhi; Sun, Xiaoqiang; Liu, Yixi; Li, Tiankai; Cheng, Heng-Jie; Cheng, Che Ping

Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2025; Vol. 392, Issue 6, pp. -. DOI: 10.1016/j.jpet.2025.103594


在线咨询

Journal Of Pharmacology And Experimental Therapeutics

国际简称:J PHARMACOL EXP THER参考译名:药理学与实验治疗学杂志

年发文量:285 CiteScore:5.2 是否预警:否 Gold OA文章占比:17.38% 研究类文章占比:88.42%

杂志社联系方式:AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 9650 ROCKVILLE PIKE, BETHESDA, USA, MD, 20814-3995

Journal Of Pharmacology And Experimental Therapeutics